Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1991 Feb;59(2):708–711. doi: 10.1128/iai.59.2.708-711.1991

Isolation and characterization of a transposon-induced cytotoxin-deficient mutant of Pseudomonas aeruginosa.

L H Bopp 1, A L Baltch 1, M C Hammer 1, M A Franke 1, R P Smith 1, F Lutz 1
PMCID: PMC257816  PMID: 1846129

Abstract

In order to provide a better system for investigating the role of cytotoxin in pathogenesis, we mutated wild-type Pseudomonas aeruginosa PA158 by introducing a transposon. The resulting pool of mutants was screened for cytotoxin-deficient strains. One mutant strain, PA114F5, was compared with PA158. Except for cytotoxin production and antibiotic resistance (specified by the transposon), the two strains appear isogenic. This mutant strain should be useful in further clarifying the role of cytotoxin in pathogenesis.

Full text

PDF
708

Images in this article

709Image
on p.709

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baltch A. L., Griffin P. E., Hammer M. Pseudomonas aeruginosa bacteremia: relationship of bacterial enzyme production and pyocine types with clinical prognosis in 100 patients. J Lab Clin Med. 1979 Apr;93(4):600–606. [PubMed] [Google Scholar]
  2. Baltch A. L., Griffin P. E. Pseudomonas aeruginosa bacteremia: a clinical study of 75 patients. Am J Med Sci. 1977 Sep-Oct;274(2):119–129. [PubMed] [Google Scholar]
  3. Baltch A. L., Hammer M. C., Smith R. P., Obrig T. G., Conroy J. V., Bishop M. B., Egy M. A., Lutz F. Effects of Pseudomonas aeruginosa cytotoxin on human serum and granulocytes and their microbicidal, phagocytic, and chemotactic functions. Infect Immun. 1985 May;48(2):498–506. doi: 10.1128/iai.48.2.498-506.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baltch A. L., Hammer M., Smith R. P., Sutphen N. Pseudomonas aeruginosa bacteremia: susceptibility of 100 blood culture isolates to seven antimicrobial agents and its clinical significance. J Lab Clin Med. 1979 Aug;94(2):201–214. [PubMed] [Google Scholar]
  5. Baltch A. L., Obrig T. G., Smith R. P., Hammer M. C., Conroy J. V., Lutz F. Production of cytotoxin by clinical strains of Pseudomonas aeruginosa. Can J Microbiol. 1987 Feb;33(2):104–111. doi: 10.1139/m87-018. [DOI] [PubMed] [Google Scholar]
  6. Bishop M. B., Baltch A. L., Hill L. A., Smith R. P., Lutz F., Pollack M. The effect of Pseudomonas aeruginosa cytotoxin and toxin A on human polymorphonuclear leukocytes. J Med Microbiol. 1987 Dec;24(4):315–324. doi: 10.1099/00222615-24-4-315. [DOI] [PubMed] [Google Scholar]
  7. Bodey G. P., Jadeja L., Elting L. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med. 1985 Sep;145(9):1621–1629. doi: 10.1001/archinte.145.9.1621. [DOI] [PubMed] [Google Scholar]
  8. Brown V. I., Lowbury E. J. Use of an improved cetrimide agar medium and other culture methods for Pseudomonas aeruginosa. J Clin Pathol. 1965 Nov;18(6):752–756. doi: 10.1136/jcp.18.6.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cross A., Allen J. R., Burke J., Ducel G., Harris A., John J., Johnson D., Lew M., MacMillan B., Meers P. Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis. 1983 Nov-Dec;5 (Suppl 5):S837–S845. doi: 10.1093/clinids/5.supplement_5.s837. [DOI] [PubMed] [Google Scholar]
  10. Flick M. R., Cluff L. E. Pseudomonas bacteremia. Review of 108 cases. Am J Med. 1976 Apr;60(4):501–508. doi: 10.1016/0002-9343(76)90716-6. [DOI] [PubMed] [Google Scholar]
  11. GLADSTONE G. P., VAN HEYNINGEN W. E. Staphylococcal leucocidins. Br J Exp Pathol. 1957 Apr;38(2):123–137. [PMC free article] [PubMed] [Google Scholar]
  12. Gillies R. R., Govan J. R. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol. 1966 Apr;91(2):339–345. doi: 10.1002/path.1700910207. [DOI] [PubMed] [Google Scholar]
  13. Godson G. N., Vapnek D. A simple method of preparing large amounts of phiX174 RF 1 supercoiled DNA. Biochim Biophys Acta. 1973 Apr 11;299(4):516–520. doi: 10.1016/0005-2787(73)90223-2. [DOI] [PubMed] [Google Scholar]
  14. Hayashi T., Kamio Y., Terawaki Y. Purification and characterization of cytotoxin from the crude extract of Pseudomonas aeruginosa. Microb Pathog. 1989 Feb;6(2):103–112. doi: 10.1016/0882-4010(89)90013-2. [DOI] [PubMed] [Google Scholar]
  15. Hirayama T., Noda M., Matsuda F., Nagamori M., Kato I. Binding of pseudomonal leukocidin to rabbit polymorphonuclear leukocytes. Infect Immun. 1984 Dec;46(3):631–634. doi: 10.1128/iai.46.3.631-634.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Holt R. J. The detection of bacterial esterases and lipases. Med Lab Technol. 1971 Apr;28(2):208–210. [PubMed] [Google Scholar]
  17. Howe T. R., Iglewski B. H. Isolation and characterization of alkaline protease-deficient mutants of Pseudomonas aeruginosa in vitro and in a mouse eye model. Infect Immun. 1984 Mar;43(3):1058–1063. doi: 10.1128/iai.43.3.1058-1063.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. JEFFRIES C. D., HOLTMAN D. F., GUSE D. G. Rapid method for determining the activity of microorganisms on nucleic acids. J Bacteriol. 1957 Apr;73(4):590–591. doi: 10.1128/jb.73.4.590-591.1957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. KING E. O., WARD M. K., RANEY D. E. Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med. 1954 Aug;44(2):301–307. [PubMed] [Google Scholar]
  20. Kluftinger J. L., Lutz F., Hancock R. E. Pseudomonas aeruginosa cytotoxin: periplasmic localization and inhibition of macrophages. Infect Immun. 1989 Mar;57(3):882–886. doi: 10.1128/iai.57.3.882-886.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Liu P. V. Extracellular toxins of Pseudomonas aeruginosa. J Infect Dis. 1974 Nov;130 (Suppl)(0):S94–S99. doi: 10.1093/infdis/130.supplement.s94. [DOI] [PubMed] [Google Scholar]
  22. Lowbury E. J., Thom B. T., Lilly H. A., Babb J. R., Whittall K. Sources of infection with Pseudomonas aeruginosa in patients with tracheostomy. J Med Microbiol. 1970 Feb;3(1):39–56. doi: 10.1099/00222615-3-1-39. [DOI] [PubMed] [Google Scholar]
  23. Lutz F. Purification of a cytotoxic protein from Pseudomonas aeruginosa. Toxicon. 1979;17(5):467–475. doi: 10.1016/0041-0101(79)90280-0. [DOI] [PubMed] [Google Scholar]
  24. Morgan M. K., Chatterjee A. K. Isolation and characterization of Tn5 insertion mutants of Pseudomonas syringae pv. syringae altered in the production of the peptide phytotoxin syringotoxin. J Bacteriol. 1985 Oct;164(1):14–18. doi: 10.1128/jb.164.1.14-18.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Murthy S. K., Baltch A. L., Smith R. P., Desjardin E. K., Hammer M. C., Conroy J. V., Michelsen P. B. Oropharyngeal and fecal carriage of Pseudomonas aeruginosa in hospital patients. J Clin Microbiol. 1989 Jan;27(1):35–40. doi: 10.1128/jcm.27.1.35-40.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nicas T. I., Iglewski B. H. Isolation and characterization of transposon-induced mutants of Pseudomonas aeruginosa deficient in production of exoenzyme S. Infect Immun. 1984 Aug;45(2):470–474. doi: 10.1128/iai.45.2.470-474.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Nicas T. I., Iglewski B. H. The contribution of exoproducts to virulence of Pseudomonas aeruginosa. Can J Microbiol. 1985 Apr;31(4):387–392. doi: 10.1139/m85-074. [DOI] [PubMed] [Google Scholar]
  28. Ohman D. E., Burns R. P., Iglewski B. H. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa. J Infect Dis. 1980 Oct;142(4):547–555. doi: 10.1093/infdis/142.4.547. [DOI] [PubMed] [Google Scholar]
  29. Ohman D. E., Cryz S. J., Iglewski B. H. Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase. J Bacteriol. 1980 Jun;142(3):836–842. doi: 10.1128/jb.142.3.836-842.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Ohman D. E., Sadoff J. C., Iglewski B. H. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization. Infect Immun. 1980 Jun;28(3):899–908. doi: 10.1128/iai.28.3.899-908.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Parsons L. M., Shayegani M., Waring A. L., Bopp L. H. DNA probes for the identification of Haemophilus ducreyi. J Clin Microbiol. 1989 Jul;27(7):1441–1445. doi: 10.1128/jcm.27.7.1441-1445.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Scharmann W. Formation and isolation of leucocidin from Pseudomonas aeruginosa. J Gen Microbiol. 1976 Apr;93(2):283–291. doi: 10.1099/00221287-93-2-283. [DOI] [PubMed] [Google Scholar]
  33. Scharmann W. Purification and characterization of leucocidin from Pseudomonas aeruginosa. J Gen Microbiol. 1976 Apr;93(2):292–302. doi: 10.1099/00221287-93-2-292. [DOI] [PubMed] [Google Scholar]
  34. Seeger W., Walmrath D., Neuhof H., Lutz F. Pulmonary microvascular injury induced by Pseudomonas aeruginosa cytotoxin in isolated rabbit lungs. Infect Immun. 1986 Jun;52(3):846–852. doi: 10.1128/iai.52.3.846-852.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Smith R. F., Willett N. P. Rapid plate method for screening hyaluronidase and chondroitin sulfatase-producing microorganisms. Appl Microbiol. 1968 Sep;16(9):1434–1436. doi: 10.1128/am.16.9.1434-1436.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sokol P. A., Ohman D. E., Iglewski B. H. A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa. J Clin Microbiol. 1979 Apr;9(4):538–540. doi: 10.1128/jcm.9.4.538-540.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Suttorp N., Seeger W., Uhl J., Lutz F., Roka L. Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: membrane attack and calcium influx. J Cell Physiol. 1985 Apr;123(1):64–72. doi: 10.1002/jcp.1041230111. [DOI] [PubMed] [Google Scholar]
  38. Woods D. E., Cryz S. J., Friedman R. L., Iglewski B. H. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect Immun. 1982 Jun;36(3):1223–1228. doi: 10.1128/iai.36.3.1223-1228.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wretlind B., Sjöberg L., Wadström T. Protease-deficient mutants of Pseudomonas aeruginosa: pleiotropic changes in activity of other extracellular enzymes. J Gen Microbiol. 1977 Dec;103(2):329–336. doi: 10.1099/00221287-103-2-329. [DOI] [PubMed] [Google Scholar]
  40. Wu D. H., Baltch A. L., Smith R. P. In vitro comparison of Pseudomonas aeruginosa isolates with various susceptibilities to aminoglycosides and ten beta-lactam antibiotics. Antimicrob Agents Chemother. 1984 Apr;25(4):488–490. doi: 10.1128/aac.25.4.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Zumft W. G., Döhler K., Körner H. Isolation and characterization of transposon Tn5-induced mutants of Pseudomonas perfectomarina defective in nitrous oxide respiration. J Bacteriol. 1985 Sep;163(3):918–924. doi: 10.1128/jb.163.3.918-924.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Zylstra G. J., McCombie W. R., Gibson D. T., Finette B. A. Toluene degradation by Pseudomonas putida F1: genetic organization of the tod operon. Appl Environ Microbiol. 1988 Jun;54(6):1498–1503. doi: 10.1128/aem.54.6.1498-1503.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES